Table 5.

Toxicities recorded in both ICI and ICI+BTT treatments.

Toxicity	Grade			Total No. (%)
	1No. (%)	2No. (%)	3No. (%)
Arthralgia	1 (2.2)	0 (0.0)	1 (2.2)	2 (4.3)
Asthenia	2 (4.3)	0 (0.0)	1 (2.2)	3 (6.5)
Dermatitis	0 (0.0)	0 (0.0)	1 (2.2)	1 (2.2)
Diarrhea	2 (4.3)	1 (2.2)	0 (0.0)	3 (6.5)
Dypnea	0 (0.0)	1 (2.2)	0 (0.0)	1 (2.2)
Infection	0 (0.0)	1 (2.2)	0 (0.0)	1 (2.2)
Creatinine increase	5 (10.9)	1 (2.2)	0 (0.0)	6 (13.0)
Hyperamylasemia	1 (2.2)	0 (0.0)	1 (2.2)	2 (4.3)
Hypertransaminasemia	2 (4.3)	0 (0.0)	1 (2.2)	3 (6.5)
Hypophosphatemia	0 (0.0)	1 (2.2)	0 (0.0)	1 (2.2)
Hypothyroidism	1 (2.2)	0 (0.0)	0 (0.0)	1 (2.2)
Neuropathy	0 (0.0)	1 (2.2)	0 (0.0)	1 (2.2)
Neutropenia	0 (0.0)	1 (2.2)	0 (0.0)	1 (2.2)
Pneumonitis	0 (0.0)	2 (4.3)	0 (0.0)	2 (4.3)
Skin rash	1 (2.2)	1 (2.2)	0 (0.0)	2 (4.3)
Lipase increase	1 (2.2)	0 (0.0)	1 (2.2)	2 (4.3)
Sepsis	0 (0.0)	0 (0.0)	1 (2.2)	1 (2.2)
Skin toxicity	0 (0.0)	0 (0.0)	1 (2.2)	1 (2.2)